* Look out below — investors are meaningfully underpricing risk. * "Slugflation" remains our base case — accompanied by a revaluation (lower) in price earnings multiples. * The Fed may be between a rock and a hard place.…
Read in context ›Bristol-Myers Squibb Stock (BMY)
Track Bristol-Myers Squibb stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
BMY
Bristol-Myers Squibb
healthcare
At close
$59.75
▼ -0.82 (-1.35%)
Oct 16, 4:00 PM ET
After-hours
$59.92
▲ +0.17 (+0.29%)
Oct 16, 7:55 PM ET
Market Cap
$123.73B
P/E Ratio
13.2x
1Y Return
+43.84%
EPS (TTM)
$4.54
Read the latest TheStreet Pro articles mentioning Bristol-Myers Squibb, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
56 articlesDaily Diary Mentions
1 mentionTrain Hundred and Two Is on the Wrong Track and Headed for You